K121762 is an FDA 510(k) clearance for the CARDIAC VX. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.
Submitted by Ge Medical Systems, LLC (Waukesha, US). The FDA issued a Cleared decision on January 18, 2013 after a review of 217 days - an extended review cycle.
This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Incremental AI imaging tool. Moderate-to-high equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.
View all Ge Medical Systems, LLC devices
NCT00877903
Completed
Interventional
Industry-sponsored
Prochymal® (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)
A Phase II, Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of PROCHYMAL® (Ex Vivo Cultured Adult Human Mesenchymal Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction
| Condition studied |
Myocardial Infarction |
| Study design |
Parallel |
| Eligibility |
All sexes
· 21 Years+
|
| Principal investigator |
Ken Borow, MD |
| Sponsor |
Mesoblast, Inc.
(industry)
|
Started 2009-03-30
→
Primary completion 2011-05-18
→
Completed 2016-03-14
Primary outcome
Change from Baseline in Cardiac Magnetic Resonance (CMR) imaging-determined End Systolic Volume (ESV) at Month 3
Secondary outcome
Left Ventricular End Systolic Volume
Study completed - no results published.
This trial concluded in 2016 but has not posted
results to ClinicalTrials.gov. Completed studies without public results are common
in industry-sponsored device trials; the data may be referenced in the
510(k) Summary PDF or remain unpublished.
View full study on ClinicalTrials.gov